Treatment Options and Antifungal Resistance in Pediatric <i>Candidozyma auris</i> (Previously <i>Candida auris</i>) Infections: A Systematic Review of Clinical Outcomes

<i>Candidozyma auris</i> (previously named <i>Candida auris</i>) has been recognized as a significant public health threat due to its extensive transmission in hospital settings, high mortality rates, and multidrug resistance. Evidence regarding optimal antifungal treatment in children remains limit...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Konstantinos Stergiou, Kanellos Skourtsidis, Georgios Kiosis, Despoina Ioannou, Vasilis-Spyridon Tseriotis, Vasileios Fouskas, Sofia Karachrysafi, Elias Iosifidis, Emmanuel Roilides, Theodora Papamitsou, Maria Kourti
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2026-01-01
Rangatū:	Microorganisms
Ngā marau:	<i>Candida auris</i> <i>Candidozyma auris</i> children neonates antifungal resistance combination therapy
Urunga tuihono:	https://www.mdpi.com/2076-2607/14/1/228
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!